ROZA SHARAIN: Open Payments
NPI 1174933675 · LINCOLNWOOD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 32 payments from 7 companies in 2025. Trend: 2023 $616 · 2024 $466 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $171 |
| Novartis Pharmaceuticals Corporation | 8 | $135 |
| Amgen Inc. | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $88 |
| SCPHARMACEUTICALS INC. | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $65 |
| Antares Pharma, Inc. | 1 | $24 |
Products named: FARXIGA, REPATHA, LEQVIO, JARDIANCE, FUROSCIX, ELIQUIS, ENTRESTO, XYOSTED.
Industry payments across IL — which companies pay providers there.
